Increased oxidative damage to DNA in ALS patients

被引:260
作者
Bogdanov, M
Brown, RH
Matson, W
Smart, R
Hayden, D
O'Donnell, H
Beal, MF
Cudkowicz, M
机构
[1] Massachusetts Gen Hosp, Neurochem Lab, Neurol Serv, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Serv Neurol, New York, NY USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY USA
[5] Massachusetts Gen Hosp, Neurol Serv, Boston, MA 02114 USA
[6] ESA Inc, Chelmsford, MA USA
[7] Massachusetts Gen Hosp, Gen Clin Res Ctr, Boston, MA USA
[8] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Clin Trial Unit, Boston, MA USA
关键词
amyotrophic lateral sclerosis; 8-hydroxy-2 '-deoxyguanosine; DNA; cerebrospinal fluid; plasma; urine; free radicals;
D O I
10.1016/S0891-5849(00)00349-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although the cause of amyotrophic lateral sclerosis (ALS) is unknown, substantial evidence indicates that oxidative toxicity is associated with neuronal death in this disease. We examined levels of a well-established marker of oxidative damage to DNA, 8-hydroxy-2'-deoxyguanosine (8OH2'dG) in plasma, urine, and cerebrospinal fluid (CSF) at a single time point from subjects with ALS, other neurological diseases, or no known disorders. We also measured the rate of change of 8OH2'dG levels in plasma and urine from ALS and in urine from control subjects over 9 months and examined the relationship to disease severity. In each fluid, 8OH2'dG levels were significantly elevated in the ALS group as compared to control subjects. In all subjects, the plasma and CSF 8OH2'dG levels increased with age, providing further evidence for a role of oxidative damage in normal aging. Plasma and urine sOH2'dG levels increased significantly with time in the ALS group only. The rate of increase in urine 8OH2'dG levels with time was significantly correlated with disease severity. These findings are consistent with the hypothesis that oxidative pathology accompanies the neurodegenerative process in ALS and suggest that 8OH2'dG may provide a useful tool for monitoring therapeutic interventions in this disease. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:652 / 658
页数:7
相关论文
共 38 条
[1]   INDUCTION OF NITROTYROSINE-LIKE IMMUNOREACTIVITY IN THE LOWER MOTOR-NEURON OF AMYOTROPHIC-LATERAL-SCLEROSIS [J].
ABE, K ;
PAN, LH ;
WATANABE, M ;
KATO, T ;
ITOYAMA, Y .
NEUROSCIENCE LETTERS, 1995, 199 (02) :152-154
[2]  
Acworth IN, 1999, METHOD ENZYMOL, V300, P297
[3]   Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis [J].
Beal, MF ;
Ferrante, RJ ;
Browne, SE ;
Matthews, RT ;
Kowall, NW ;
Brown, RH .
ANNALS OF NEUROLOGY, 1997, 42 (04) :644-654
[4]   ALS, SOD AND PEROXYNITRITE [J].
BECKMAN, JS ;
CARSON, M ;
SMITH, CD ;
KOPPENOL, WH .
NATURE, 1993, 364 (6438) :584-584
[5]   Oxidative decay of DNA [J].
Beckman, KB ;
Ames, BN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (32) :19633-19636
[6]   A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2 '-deoxyguanosine measurements in urine and other biologic matrices: A one-year evaluation of methods [J].
Bogdanov, MB ;
Beal, MF ;
McCabe, DR ;
Griffin, RM ;
Matson, WR .
FREE RADICAL BIOLOGY AND MEDICINE, 1999, 27 (5-6) :647-666
[7]  
Bogdanov MB, 1998, J NEUROCHEM, V71, P1321
[8]   SUPEROXIDE-DISMUTASE ACTIVITY, OXIDATIVE DAMAGE, AND MITOCHONDRIAL ENERGY-METABOLISM IN FAMILIAL AND SPORADIC AMYOTROPHIC-LATERAL-SCLEROSIS [J].
BOWLING, AC ;
SCHULZ, JB ;
BROWN, RH ;
BEAL, MF .
JOURNAL OF NEUROCHEMISTRY, 1993, 61 (06) :2322-2325
[9]   Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant [J].
Bruijn, LI ;
Beal, MF ;
Becher, MW ;
Schulz, JB ;
Wong, PC ;
Price, DL ;
Cleveland, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) :7606-7611
[10]  
CEDARBAUM J, 1996, ARCH NEUROL-CHICAGO, V53, P141